4.2(top 10%)
impact factor
2.0K(top 10%)
papers
10.9K(top 20%)
citations
41(top 20%)
h-index
4.3(top 10%)
extended IF
2.1K
all documents
12.5K
doc citations
70(top 20%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | Cancer incidence and mortality in China, 2014 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 776 |
| 2 | Liver cancer incidence and mortality in China: Temporal trends and projections to 2030 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 246 |
| 3 | Cancer incidence and mortality in China in 2013: an analysis based on urbanization level | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 220 |
| 4 | Cervical cancer: Epidemiology, risk factors and screening | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 200 |
| 5 | Incidence and mortality of stomach cancer in China, 2014 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 156 |
| 6 | Antioxidant enzymes and cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2010 | 144 |
| 7 | Updates on larynx cancer epidemiology | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 134 |
| 8 | Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 134 |
| 9 | Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 127 |
| 10 | Gastric cancer: Epidemiology, risk factors and prevention strategies | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 127 |
| 11 | Cancer burden and trends in China: A review and comparison with Japan and South Korea | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 123 |
| 12 | Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 118 |
| 13 | Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 95 |
| 14 | Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 92 |
| 15 | Validation and reliability of distress thermometer in Chinese cancer patients | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 90 |
| 16 | Cancer incidence and mortality in China, 2007 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 90 |
| 17 | Overproduction of reactive oxygen species – obligatory or not for induction of apoptosis by anticancer drugs | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 87 |
| 18 | Report of incidence and mortality in China Cancer Registries, 2008 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 84 |
| 19 | Esophageal cancer: Epidemiology, risk factors and screening | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 84 |
| 20 | Epidemiology and risk factors of colorectal cancer in China | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 73 |
| 21 | Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 69 |
| 22 | Incidence and mortality of laryngeal cancer in China, 2008−2012 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 67 |
| 23 | High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 64 |
| 24 | Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 64 |
| 25 | Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 61 |
| 26 | Individualized prediction of perineural invasion in colorectal cancer: development and validation of a radiomics prediction model | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 58 |
| 27 | Expenditure of hospital care on cancer in China, from 2011 to 2015 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 58 |
| 28 | Tumor immunotherapy: New aspects of natural killer cells | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 56 |
| 29 | Immune signature profiling identified prognostic factors for gastric cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 56 |
| 30 | Screening for gastric cancer in China: Advances, challenges and visions | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 56 |
| 31 | Incidence and mortality of thyroid cancer in China, 2008−2012 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 56 |
| 32 | Cancer incidence and mortality in China, 2006 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 55 |
| 33 | Incidence and mortality of cervical cancer in China, 2013 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 54 |
| 34 | Induction of the apoptosis of cancer cell by sonodynamic therapy: a review | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 53 |
| 35 | Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 53 |
| 36 | Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 52 |
| 37 | Colorectal cancer burden and trends: Comparison between China and major burden countries in the world | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 52 |
| 38 | Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 51 |
| 39 | Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 51 |
| 40 | Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 48 |
| 41 | Chemotherapy and molecular targeting therapy for recurrent cervical cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 47 |
| 42 | Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 46 |
| 43 | Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 46 |
| 44 | Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 45 |
| 45 | Boron neutron capture therapy for malignant melanoma: first clinical case report in China | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 45 |
| 46 | HCA520, a novel tumor associated antigen, involved in cell proliferation and apoptosis | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2003 | 43 |
| 47 | Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 42 |
| 48 | Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 42 |
| 49 | Factors affecting mesenchymal stromal cells yield from bone marrow aspiration | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 41 |
| 50 | Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 41 |